Ftse Mib
34.492,41
0,13%
DAX
18.497,94
-0,09%
S&P 500
5.277,51
0,80%
NASDAQ
16.735,02
-0,01%
Bitcoin
67.610,25
0,19%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Targanta Therapeutics Corp (MM) (TARG) Targanta Therapeutics Corp (MM) (TARG) Notizie

TARG

Targanta Therapeutics Corp (MM) (TARG)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:TARG
DataOraFonteTitoloSimboloCompagnia
26/02/200912:06Edgar (US Regulatory)(25-NSE)NASDAQ:TARGTarganta Therapeutics Corp (MM)
25/02/200916:50Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:TARGTarganta Therapeutics Corp (MM)
25/02/200916:05Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:TARGTarganta Therapeutics Corp (MM)
25/02/200916:05Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:TARGTarganta Therapeutics Corp (MM)
25/02/200914:30MarketwiredThe Medicines Company Announces Completion of Tender Offer for Shares of Targanta TherapeuticsNASDAQ:TARGTarganta Therapeutics Corp (MM)
20/02/200913:58Business WireTarganta Enters into Memorandum of Understanding to Resolve Shareholder LawsuitNASDAQ:TARGTarganta Therapeutics Corp (MM)
17/02/200922:12Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:TARGTarganta Therapeutics Corp (MM)
27/01/200920:43Edgar (US Regulatory)Statement of Ownership: Solicitation (SC 14D9)NASDAQ:TARGTarganta Therapeutics Corp (MM)
27/01/200919:08MarketwiredThe Medicines Company Commences Tender Offer for All Outstanding Shares of Targanta TherapeuticsNASDAQ:TARGTarganta Therapeutics Corp (MM)
27/01/200918:54Edgar (US Regulatory)Tender offer statement by Third Party (SC TO-T)NASDAQ:TARGTarganta Therapeutics Corp (MM)
27/01/200912:04Edgar (US Regulatory)Written communication by the subject company relating to a third party tender offer (SC14D9C)NASDAQ:TARGTarganta Therapeutics Corp (MM)
27/01/200912:01Edgar (US Regulatory)Written communication relating to an issuer or third party (SC TO-C)NASDAQ:TARGTarganta Therapeutics Corp (MM)
22/01/200922:49Edgar (US Regulatory)Statement of Beneficial Ownership (SC 13D)NASDAQ:TARGTarganta Therapeutics Corp (MM)
14/01/200923:20Edgar (US Regulatory)Current report filing (8-K)NASDAQ:TARGTarganta Therapeutics Corp (MM)
13/01/200904:34MarketwiredThe Medicines Company to Acquire Targanta TherapeuticsNASDAQ:TARGTarganta Therapeutics Corp (MM)
18/12/200822:05Business WireTarganta Announces Corporate RestructuringNASDAQ:TARGTarganta Therapeutics Corp (MM)
09/12/200805:52Business WireFDA Issues Complete Response Letter for OritavancinNASDAQ:TARGTarganta Therapeutics Corp (MM)
03/12/200812:00Edgar (US Regulatory)Notice of Effectiveness (EFFECT)NASDAQ:TARGTarganta Therapeutics Corp (MM)
25/11/200820:49Edgar (US Regulatory)Confidential Treatment Order (CT ORDER)NASDAQ:TARGTarganta Therapeutics Corp (MM)
24/11/200816:32Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TARGTarganta Therapeutics Corp (MM)
20/11/200803:17Business WireFDA Advisory Committee Provides Opinion on Oritavancin for the Treatment of Complicated Skin and Skin Structure InfectionsNASDAQ:TARGTarganta Therapeutics Corp (MM)
18/11/200815:52Edgar (US Regulatory)Securities Registration Statement (simplified form) (S-3)NASDAQ:TARGTarganta Therapeutics Corp (MM)
17/11/200818:29Business WireTarganta Announces Posting of Briefing Documents for Review of FDA Anti-Infective Drugs Advisory Committee Meeting for Oritav...NASDAQ:TARGTarganta Therapeutics Corp (MM)
12/11/200814:02Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:TARGTarganta Therapeutics Corp (MM)
12/11/200813:58Business WireTarganta Reports Third-Quarter 2008 Financial ResultsNASDAQ:TARGTarganta Therapeutics Corp (MM)
05/11/200813:58Business WireTarganta Therapeutics to Present at November 2008 Investor ConferencesNASDAQ:TARGTarganta Therapeutics Corp (MM)
26/10/200817:15Business WireTarganta Presents Efficacy & Safety Data for Oritavancin for the Treatment of Gram-Positive Complicated Skin & Skin Structure...NASDAQ:TARGTarganta Therapeutics Corp (MM)
26/10/200816:15Business WireTarganta Therapeutics Presents Data on Mechanisms That Underly Oritavancin’s Bactericidal ActivityNASDAQ:TARGTarganta Therapeutics Corp (MM)
25/10/200818:15Business WireTarganta Presents Preclinical In Vivo Data Demonstrating Activity of Oritavancin against Clostridium Difficile InfectionNASDAQ:TARGTarganta Therapeutics Corp (MM)
25/10/200818:15Business WireTarganta Therapeutics Presents In Vitro Data Highlighting Oritavancin’s Potent Activity Against Gram-Positive PathogensNASDAQ:TARGTarganta Therapeutics Corp (MM)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:TARG

La tua Cronologia

COIN
ZSEGBP
BIT
P20CQ3
NLBNPIT20CQ3 20240621 1200
BIT
CWF
Exchange Traded
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network